Monarch Beach, CA, United States of America

Lakshman R Sehgal

This inventor holds 27 USPTO granted patents and 5 published patent applications and 1 EPO patent, primarily in Gene Therapy. Top assignees: Biovec, LLC, Biovec Transfusion, LLC. Active years: 2007-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lakshman R Sehgal. Retrieved from https://idiyas.com/inventor/lakshman-r-sehgal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 (Patent Applications = 5)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 1.5

ph-index = 6

Forward Citations = 82(Granted Patents)

Location History:

Glenview, IL (US) (2007 - 2010)
Dana Point, CA (US) (2013 - 2015)
Monarch Beach, CA (US) (2009 - 2016)

Company Filing History:

Biovec Transfusion, LLC

patents

Years Active: 2007-2016

Loading Chart...

Areas of Expertise:

Gene Transfer

Platelet Preservation

Adenovirus Vectors

Cardiovascular Treatment

Thrombomodulin

Antiplatelet Agents

Anticoagulants

Pathogen Removal

Oxygen Carriers

Renal Tissue

Composition Methods

Diafiltration

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9388427 - In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors (2016-07-12),

2. 9353383 - Vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors (2016-05-31),

3. 9095818 - Method of filtering platelets to remove antiplatelet and anticoagulant agents (2015-08-04),

4. 8927203 - Platelet preservation package comprising a short to ultra-short acting antiplatelet agent and anticoagulant (2015-01-06),

5. 8877060 - Methods for removing pathogens from a platelet preparation (2014-11-04),

6. 8715920 - Composition for preserving platelets during photosensitization (2014-05-06),

7. 8697347 - Composition for preserving platelets and method of using the same (2014-04-15),

8. 8470521 - Method for removing antiplatelet agent and anticoagulant from a platelet composition by diafiltration (2013-06-25),

9. 8431334 - Method for removing antiplatelet agent and anticoagulant from a platelet composition by diafiltration (2013-04-30),

10. 8420075 - Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of cardiovascular and peripheral vascular diseases (2013-04-16),

11. 8367056 - In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors (2013-02-05),

12. 8329389 - Composition containing short-to-ultrashort GPIIb/IIIa and factor Xa inhibitors and platelets (2012-12-11),

13. 8242095 - In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors (2012-08-14),

14. 8236300 - In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors (2012-08-07),

15. 8232044 - Method of extending the shelf life of platelets using a composition comprising a short-to-ultrashort antiplatelet agent and anticoagulant and an oxygen carrier (2012-07-31),

Title: The Inventor Journey of Lakshman R Sehgal

Introduction

Lakshman R Sehgal, a prolific inventor based in Monarch Beach, CA, has made significant contributions to the field of gene therapy with a total of 27 patents to his name. His innovative work in gene transfer techniques has paved the way for novel treatments in renal diseases.

Latest Patents

Sehgal's latest patents focus on in vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vectors. These breakthrough methods involve administering gutless adenoviral vectors containing specific polynucleotides to express therapeutic agents in kidney tissues, offering promising solutions for treating renal diseases effectively.

Career Highlights

Throughout his career, Sehgal has showcased his expertise while working at reputable companies such as Biovec, LLC and Biovec Transfusion, LLC. His dedication to advancing gene therapy technologies has been instrumental in shaping the landscape of medical treatments.

Collaborations

Sehgal has collaborated closely with esteemed colleagues in the field, including Jonathan Wong and Shaker A Mousa. Together, they have synergized their skills and knowledge to push the boundaries of gene therapy and enhance patient care outcomes.

Conclusion

Lakshman R Sehgal's pioneering work in gene therapy and renal disease treatments has marked him as a standout inventor in the industry. With his innovative patents and collaborative efforts, he continues to make a profound impact on the field of biotechnology and holds promise for the future of medical advancements.

Profile summary based on public USPTO records.